FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Zynex Files 510(k) for CO-Oximeter Device

Zynex files a 510(k) for its NiCO, Noninvasive CO-Oximeter device that relies on the companys laser technology.

Biologics

Moderna Withdraws Pending BLA for Flu/Covid Vaccine

Moderna, at FDAs urging, voluntarily withdraws a pending BLA for mRNA-1083, its flu/COVID combination vaccine candidate.

latest-news-card-1
Medical Devices

QS Violations in NeuroSync Inspection

FDA warns Holliston, MA-based NeuroSync about Quality System regulation and other violations in its manufacturing of the Eye-Sync eye assessment medic...

latest-news-card-1
Medical Devices

Ethicon Endo-Surgery Recalls Surgical Stapler

Johnson & Johnsons Ethicon Endo-Surgery recalls its Endopath Echelon Vascular White Reload for Advanced Placement Tip surgical stapler due to increase...

latest-news-card-1
Human Drugs

48 New, Revised PSGs Out

FDA publishes 34 new and 14 revised product-specific guidances to aid in generic drug development.

latest-news-card-1
FDA General

Miller Named Acting Inspections Chief

FDA names Elizabeth Miller acting associate commissioner of the Office of Inspections and Investigations (OII), replacing Michael Rogers, who retired ...

latest-news-card-1
Marketing

FDA Warns Sarfez About Soaanz Promotional Materials

The CDER Office of Prescription Drug Promotion warns Sarfez Pharmaceuticals that promotional materials for its Soaanz edema drug contain false and mis...

Biologics

Covid Vaccine Policy on Boosters and New Trials

FDA commissioner Marty Makary and CBER director Vinay Prasad outline a new regulatory framework for annual Covid-19 booster shots and call for new cl...

latest-news-card-1
Human Drugs

SSRI/SNRI Labeling Changes Sought

The Antidepressant Coalition for Education petitions FDA to change labeling for selective serotonin reuptake inhibitors and serotonin-norepinephrine r...

latest-news-card-1
Human Drugs

FDA Approves Bayers Jivi Antihemophilic Factor

FDA expands its approval of Bayers Jivi for the routine prophylactic treatment of hemophilia A in previously treated adult and pediatric patients aged...